While the world obsesses over AI and fintech, a quiet $38.7M revenue machine is managing the drug testing backbone for millions of workers. eScreen isn't just checking boxes—it's building the invisible infrastructure that keeps America's workforce clean and compliant.

"eScreen doesn't sell drug tests—it sells certainty. In a $2.5B industry plagued by fraud and delays, they've built a trusted network that enterprise HR teams rely on daily."

The keyword data reveals their hidden SEO strategy: 'escreen123' (690 monthly searches) and 'escreen federated identity management' (490 searches) suggest they're solving authentication pain points for enterprise clients. This isn't just about drug testing—it's about secure, compliant identity verification at scale. The 'near me' searches (230/month) hint at their physical collection site network, a moat that pure digital players can't replicate.

• Technology-enabled TPA (Third-Party Administrator) model—hybrid of software and physical services
• Abbott-owned infrastructure (terms link points to abbott.com) suggests pharma-grade compliance
• Federated identity management focus—enterprise authentication as a core differentiator
• 10-panel rapid standard tests dominate their keyword footprint—targeting regulated industries